YGION Biomedical is an Austrian biotechnology firm committed to making personalized cancer immunotherapy a reality.
YGION Biomedical has raised $16.3M in total funding. The most recent round was Series A. The last funding was announced in May 2024.
YGION Biomedical is headquartered in Vienna, Austria.
YGION Biomedical is an Austrian biotechnology firm committed to making personalized cancer immunotherapy a reality.
YGION Biomedical is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"YGION Biomedical — Funding & Investors." VCBacked, May 21, 2024, https://www.vcbacked.co/company/ygion-biomedical. Accessed November 13, 2026.
VCBacked. (2024). YGION Biomedical — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/ygion-biomedical
{{cite web |title=YGION Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/ygion-biomedical |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at YGION Biomedical? Request a listing update